Figure 1.

Effect of masitinib on WST-1 conversion. Masitinib treatment (100 nM) reduced the metabolic activity of C2 cells by 54% after 24 hours of treatment. The metabolic activity further decreased up to 40% at 72 hours. Data shown represent the means+/−SD of five independent experiments with C2 cells, each performed in three to five wells.

Klopfleisch et al. BMC Veterinary Research 2012 8:96   doi:10.1186/1746-6148-8-96
Download authors' original image